Document Detail


Prognostic factors for renal amyloidosis: a clinicopathological study using cluster analysis.
MedLine Citation:
PMID:  17329915     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: There is no standardized therapy for renal amyloidosis, which shows rapid progression and poor prognosis. Here, we used cluster analysis to examine the correlation between amyloid-related renal damage and prognosis, and determined the clinicopathological prognostic factors for renal amyloidosis. METHODS AND PATIENTS: We analyzed 125 patients with renal amyloidosis (men/women: 43/82; mean age at renal biopsy: 58.8+/-11.1 years, +/-SD; range: 21-78 years). Cluster analysis was performed using clinical parameters, renal histological findings, type of renal amyloidosis, and follow-up data. We also analyzed survival data. RESULTS: We divided 125 cases (prognosis was checked in 97 [77.6%] cases) into three groups by cluster analysis. In the cluster groups, accelerated progression correlated with serum creatinine (s-Cr) levels at renal biopsy and histological grade of renal damage by amyloid deposition (p<0.0001). The most important prognostic factors were glomerular, tubulointerstitial, and vascular lesions induced by amyloid deposition at biopsy (p<0.0001). We also found that amyloid-A (AA) type amyloidosis correlated is more significantly with amyloid-mediated vascular (P=0.0010) and tubulointerstitial lesions (p=0.0705) than with amyloid-L (AL) type amyloidosis. Proteinuria and nephrotic syndrome were more severe in AL than AA amyloidosis (p=0.0836). The 10-year individual survival rate was about 20%, and most deaths were due to cardiovascular disease and infection. CONCLUSION: Our results indicate that the quantity of amyloid deposition in the kidney, and the extent of glomerular, tubulointerstitial, and vascular damage are significant renal prognostic factors in amyloidosis.
Authors:
Yoshie Sasatomi; Hiroshi Sato; Yoshiro Chiba; Yasuhiro Abe; Seiji Takeda; Satoru Ogahara; Toshiaki Murata; Hidetoshi Kaneoka; Shigeo Takebayashi; Hiroshi Iwasaki; Takao Saito
Related Documents :
11867955 - Remission of nephrotic syndrome due to aa amyloidosis and initiation of glomerular repa...
11519085 - Fatal pulmonary-renal syndrome manifested with immune complex crescentic glomerulonephr...
12460065 - An unusual recurrence of crescentic nephritis after renal transplantation for iga nephr...
2206225 - Failure of two subsequent renal grafts by anti-gbm glomerulonephritis in alport's syndr...
11867955 - Remission of nephrotic syndrome due to aa amyloidosis and initiation of glomerular repa...
21927575 - Diverse roles of tgf-β/smads in renal fibrosis and inflammation.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't     Date:  2007-03-01
Journal Detail:
Title:  Internal medicine (Tokyo, Japan)     Volume:  46     ISSN:  1349-7235     ISO Abbreviation:  Intern. Med.     Publication Date:  2007  
Date Detail:
Created Date:  2007-03-01     Completed Date:  2007-04-09     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9204241     Medline TA:  Intern Med     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  213-9     Citation Subset:  IM    
Affiliation:
Division of Nephrology & Rheumatology, Department of Internal Medicine, Fukuoka University School of Medicine, Fukuoka, Japan. sasatomi@fukuoka-u.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Amyloid / metabolism
Amyloidosis / complications,  pathology*,  physiopathology*
Blood Vessels / pathology
Cluster Analysis
Creatinine / blood
Disease Progression
Female
Heart / physiopathology
Humans
Kidney / blood supply,  metabolism,  pathology
Kidney Diseases / complications,  pathology*,  physiopathology*
Kidney Tubules / pathology
Male
Middle Aged
Multivariate Analysis
Nephrotic Syndrome / complications,  physiopathology
Prognosis
Proteinuria / complications,  physiopathology
Serum Amyloid A Protein / metabolism
Severity of Illness Index
Survival Analysis
Chemical
Reg. No./Substance:
0/Amyloid; 0/Serum Amyloid A Protein; 0/amyloid L, human; 60-27-5/Creatinine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hyperglycemia promotes microinflammation as evaluated by C-reactive protein in the very elderly.
Next Document:  Clinical study of 7 cases of familial Mediterranean fever with MEFV gene mutation.